Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, <em class="a-plus-plus">i.e.</em>, increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and <em class="a-plus-plus">ex vivo</em> molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes.</p>

Development of mass spectrometry imaging techniques and its latest applications

Mass Spectrometry Imaging Techniques: Non-Ambient and Ambient Ionization Approaches

Mass Spectrometry Imaging and Its Application in Biomedical Fields

Recent Advances in Ambient Mass Spectrometry Imaging

Application progress of Mass Spectrometry Imaging technology in marine biology research

Advances in Mass Spectrometry Imaging and Its Application

Next Generation of Mass Spectrometry Imaging: from Micrometer to Subcellular Resolution

Recent advancement and applications of mass spectrometry imaging

Mass Spectrometry Imaging: Applications in Drug Distribution Studies

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Postionization Mass Spectrometry Imaging: Past, Present, and Future

Emerging Technologies in Mass Spectrometry Imaging

Updated Progress on Mass Spectrometry Imaging and its Application in Cancer Treatment and Drug Discovery

A vision for better health: mass spectrometry imaging for clinical diagnostics.

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

High-throughput mass spectrometry imaging of biological systems: Current approaches and future directions

Advances in MALDI Mass Spectrometry Imaging Single Cell and Tissues

Mass Spectrometry Imaging for Biomedical Applications

Recent Advances in Mass Spectrometry Imaging Combined with Artificial Intelligence for Spatially Clarifying Molecular Profiles: Toward Biomedical Applications

Mass spectrometry imaging for in situ analysis of endogenous molecules in plants